Methyl 3-(furan-2-amido)-4-(4-phenylpiperazin-1-yl)benzoate

Catalog No.: 
ACIONP201
CAS No.: 
439096-99-8
Molecular Formula: 
C23H23N3O4
Molecular Weight: 
405.45
Methyl 3-(furan-2-amido)-4-(4-phenylpiperazin-1-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$105.00InquiryInquiry
1g90%$322.00InquiryInquiry
5g90%$1578.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(furan-2-amido)-4-(4-phenylpiperazin-1-yl)benzoate
IUPAC Namemethyl 3-(furan-2-carboxamido)-4-(4-phenylpiperazin-1-yl)benzoate
Molecular FormulaC23H23N3O4
Molecular Weight405.45
SMILESO=C(OC)C1=CC=C(N2CCN(C3=CC=CC=C3)CC2)C(NC(C4=CC=CO4)=O)=C1
InChI KeyZLQXGOCPUKHRQG-UHFFFAOYSA-N
Synonymmethyl 3-(furan-2-amido)-4-(4-phenylpiperazin-1-yl)benzoate;METHYL 3-[(2-FURYLCARBONYL)AMINO]-4-(4-PHENYLPIPERAZINO)BENZENECARBOXYLATE;Benzoic acid, 3-[(2-furanylcarbonyl)amino]-4-(4-phenyl-1-piperazinyl)-, methyl ester
CAS No.439096-99-8

Synthetic Route by SureRoute

1. ACIONP201 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIONP201 route product structure diagram
    ACIONP201439096-99-8
Inquiry

2. ACIONP201 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIONP201 route product structure diagram
    ACIONP201439096-99-8
Inquiry

3. ACIONP201 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIONP201 route product structure diagram
    ACIONP201439096-99-8
Inquiry

Comments (0)